Microdosing psychedelics: More questions than answers? An overview and suggestions for future research

Kim P. C. Kuypers, Livia Ng, David Erritzoe, Gitte M. Knudsen, Charles D. Nichols, David E. Nichols, Luca Pani, Anais Soula, David Nutt*

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

Original languageEnglish
Pages (from-to)1039-1057
Number of pages19
JournalJournal of Psychopharmacology
Volume33
Issue number9
Early online date14 Jul 2019
DOIs
Publication statusPublished - Sep 2019

Keywords

  • Psychedelics
  • microdosing
  • psychoactive substances
  • LSD
  • dosing
  • pharmacokinetics
  • psilocybin
  • psychedelics
  • LYSERGIC-ACID DIETHYLAMIDE
  • LIFE-THREATENING CANCER
  • GENE-EXPRESSION
  • PSILOCYBIN TREATMENT
  • SEROTONIN RECEPTORS
  • HEALTHY HUMANS
  • ANIMAL-MODEL
  • DOUBLE-BLIND
  • ACTIVATION

Cite this

Kuypers, K. P. C., Ng, L., Erritzoe, D., Knudsen, G. M., Nichols, C. D., Nichols, D. E., Pani, L., Soula, A., & Nutt, D. (2019). Microdosing psychedelics: More questions than answers? An overview and suggestions for future research. Journal of Psychopharmacology, 33(9), 1039-1057. https://doi.org/10.1177/0269881119857204